Chylothorax and Cholesterol Pleural Effusion

ABSTRACT

A chylothorax and a cholesterol pleural effusion represent the two forms of lipid effusions encountered. Traditionally, a lipid pleural effusion is characterized by the presence of milky fluid. Although these two effusions often share a similar pleural fluid appearance due to the high lipid concentration, they have major differences in the pathogenesis, clinical presentation, diagnosis, predisposing conditions, and management of these effusions. A chylothorax is defined by the presence of chyle in the pleural space resulting from obstruction or disruption of the thoracic duct or one of its major tributaries. A triglyceride concentration > 110 mg/dL is virtually diagnostic, but the presence of chylomicrons confirms the diagnosis. However, a chylothorax defined by these criteria represents a heterogeneous group of clinical entities. The presence of chylomicrons or triglyceride levels > 110 mg/dL in a pleural effusion should be considered evidence of chyle leakage of indeterminate clinical significance. Many cases of a chylous effusion may be associated with other causes of pleural fluid formation. In the case of an acute or chronic chylothorax due to recent or remote thoracic duct injury, this assessment is essential, as surgical ligation of the thoracic duct is often entertained. In other cases, especially lymphoma or chylous ascites, treatment of the underlying condition is indicated regardless, and the assessment of the response to treatment is a reasonable initial approach. In contrast, a cholesterol effusion is typically the result of long-standing pleurisy with elevated cholesterol levels in the pleural space; however, this paradigm has been challenged. Lung entrapment with thickened parietal and visceral pleural membranes is the typical radiographic findings of a cholesterol effusion. Most cases of cholesterol pleural effusions are attributed to tuberculous or rheumatoid pleurisy. Decortication is the mainstay of treatment for a cholesterol effusion in symptomatic patients with restrictive lung function.

KEYWORDS

Chylothorax - cholesterol effusion - pseudochylothorax - review

REFERENCES

• 1 Agrawal V, Sahn S A. Lipid pleural effusions.  Am J Med Sci. 2008;  335 16-20
• 2 Doerr C H, Miller D L, Ryu J H. Chylothorax.  Semin Respir Crit Care Med. 2001;  22 617-626
• 3 Staats B A, Ellefson R D, Budahn L L, Dines D E, Prakash U B, Offord K. The lipoprotein profile of chylous and nonchylous pleural effusions.  Mayo Clin Proc. 1980;  55 700-704
• 4 Merrigan B A, Winter D C, O'Sullivan G C. Chylothorax.  Br J Surg. 1997;  84 15-20
• 5 Nair S K, Petko M, Hayward M P. Aetiology and management of chylothorax in adults.  Eur J Cardiothorac Surg. 2007;  32 362-369
• 6 Zilversmit D B. The composition and structure of lymph chylomicrons in dog, rat, and man.  J Clin Invest. 1965;  44 1610-1622
• 7 Van Pernis P A. Variations of the thoracic duct.  Surgery. 1949;  26 806-809
• 8 McGrath E E, Blades Z, Anderson P B. Chylothorax: aetiology, diagnosis and therapeutic options.  Respir Med. 2010;  104 1-8
• 9 Valentine V G, Raffin T A. The management of chylothorax.  Chest. 1992;  102 586-591
• 10 Doerr C H, Allen M S, Nichols III F C, Ryu J H. Etiology of chylothorax in 203 patients.  Mayo Clin Proc. 2005;  80 867-870
• 11 Fairfax A J, McNabb W R, Spiro S G. Chylothorax: a review of 18 cases.  Thorax. 1986;  41 880-885
• 12 Bolger C, Walsh T N, Tanner W A, Keeling P, Hennessy T P. Chylothorax after oesophagectomy.  Br J Surg. 1991;  78 587-588
• 13 Dougenis D, Walker W S, Cameron E W, Walbaum P R. Management of chylothorax complicating extensive esophageal resection.  Surg Gynecol Obstet. 1992;  174 501-506
• 14 Orringer M B, Bluett M, Deeb G M. Aggressive treatment of chylothorax complicating transhiatal esophagectomy without thoracotomy.  Surgery. 1988;  104 720-726
• 15 Suemitsu R, Ondo K, Fukuyama S, Ueda H. Late-period-onset chylothorax after a pulmonary resection for lung cancer: a case report.  Ann Thorac Cardiovasc Surg. 2007;  13 345-348
• 16 Halldorsson A. Chylothorax after coronary artery bypass grafting.  Int Surg. 2009;  94 119-129
• 17 Zaidenstein R, Cohen N, Dishi V, Alon I, Golik A, Modai D. Chylothorax following median sternotomy.  Clin Cardiol. 1996;  19 910-912
• 18 Ng R S, Kerbavaz R J, Hilsinger Jr R L. Bilateral chylothorax from radical neck dissection.  Otolaryngol Head Neck Surg. 1985;  93 814-817
• 19 Han C, Guo L, Wang K J, Zhao J Q. Bilateral chylothorax following neck dissection for thyroid cancer.  Int J Oral Maxillofac Surg. 2009;  38 1119-1122
• 20 Patel N, Lewandowski R J, Bove M, Nemcek Jr A A, Salem R. Thoracic duct embolization: a new treatment for massive leak after neck dissection.  Laryngoscope. 2008;  118 680-683
• 21 Busquets J M, Rullan P J, Trinidad-Pinedo J. Bilateral chylothorax after neck dissection.  Otolaryngol Head Neck Surg. 2004;  130 492-495
• 22 Kurekci E, Kaye R, Koehler M. Chylothorax and chylopericardium: a complication of a central venous catheter.  J Pediatr. 1998;  132 1064-1066
• 23 Silen M L, Weber T R. Management of thoracic duct injury associated with fracture-dislocation of the spine following blunt trauma.  J Trauma. 1995;  39 1185-1187
• 24 Worthington M G, de Groot M, Gunning A J, von Oppell U O. Isolated thoracic duct injury after penetrating chest trauma.  Ann Thorac Surg. 1995;  60 272-274
• 25 Cammarata S K, Brush Jr R E, Hyzy R C. Chylothorax after childbirth.  Chest. 1991;  99 1539-1540
• 26 Agrawal V, Doelken P, Sahn S A. Seat belt-induced chylothorax: a cause of idiopathic chylothorax?.  Chest. 2007;  132 690-692
• 27 Reilly K M, Tsou E. Bilateral chylothorax: a case report following episodes of stretching.  JAMA. 1975;  233 536-537
• 28 Parker J M, Torrington K G, Phillips Y Y. Sarcoidosis complicated by chylothorax.  South Med J. 1994;  87 860-862
• 29 Lengyel R J, Shanley D J. Recurrent chylothorax associated with sarcoidosis.  Hawaii Med J. 1995;  54 817-818
• 30 Aberg H, Bah M, Waters A W. Sarcoidosis: complicated by chylothorax.  Minn Med. 1966;  49 1065-1070
• 31 Rabie H, Lomp A, Goussard P, Nel E, Cotton M. Paradoxical tuberculosis associated immune reconstitution inflammatory syndrome presenting with chylous ascites and chylothorax in a HIV-1 infected child.  J Trop Pediatr. 2010;  56 355-358
• 32 Goh K L, Tan H W, Loh T G, Yap S. Chylothorax due to filariasis—a case report.  Singapore Med J. 1986;  27 173-176
• 33 Almoosa K F, McCormack F X, Sahn S A. Pleural disease in lymphangioleiomyomatosis.  Clin Chest Med. 2006;  27 355-368
• 34 Ryu J H, Doerr C H, Fisher S D, Olson E J, Sahn S A. Chylothorax in lymphangioleiomyomatosis.  Chest. 2003;  123 623-627
• 35 King P A, Ghosh A, Tang M H, Lam S K. Recurrent congenital chylothorax.  Prenat Diagn. 1991;  11 809-811
• 36 Hillerdal G. Yellow nail syndrome: treatment with octreotide.  Clin Respir J. 2007;  1 120-121
• 37 Maldonado F, Ryu J H. Yellow nail syndrome.  Curr Opin Pulm Med. 2009;  15 371-375
• 38 Lee S, Finn L, Sze R W, Perkins J A, Sie K C. Gorham Stout syndrome (disappearing bone disease): two additional case reports and a review of the literature.  Arch Otolaryngol Head Neck Surg. 2003;  129 1340-1343
• 39 Goldblatt M, Huggins J T, Doelken P, Gurung P, Sahn S A. Dasatinib-induced pleural effusions: a lymphatic network disorder?.  Am J Med Sci. 2009;  338 414-417
• 40 Agrawal V, Doelken P, Sahn S A. Pleural fluid analysis in chylous pleural effusion.  Chest. 2008;  133 1436-1441
• 41 Maldonado F, Hawkins F J, Daniels C E, Doerr C H, Decker P A, Ryu J H. Pleural fluid characteristics of chylothorax.  Mayo Clin Proc. 2009;  84 129-133
• 42 Al-Zubairy S A, Al-Jazairi A S. Octreotide as a therapeutic option for management of chylothorax.  Ann Pharmacother. 2003;  37 679-682
• 43 Rimensberger P C, Müller-Schenker B, Kalangos A, Beghetti M. Treatment of a persistent postoperative chylothorax with somatostatin.  Ann Thorac Surg. 1998;  66 253-254
• 44 Mares D C, Mathur P N. Medical thoracoscopic talc pleurodesis for chylothorax due to lymphoma: a case series.  Chest. 1998;  114 731-735
• 45 Rizzardi G, Loy M, Marulli G, Rea F. Persistent chylothorax in lymphangioleiomyomatosis treated by intrapleural instillation of povidone.  Eur J Cardiothorac Surg. 2008;  34 214-215
• 46 Jianjun Q, Song Z, Yin L, Jia Z, Donglei L. Treatment of chylothorax with elemene.  Thorac Cardiovasc Surg. 2008;  56 103-105
• 47 Cope C. Percutaneous transabdominal embolization of thoracic duct lacerations in animals.  J Vasc Interv Radiol. 1996;  7 725-731
• 48 Cope C, Salem R, Kaiser L R. Management of chylothorax by percutaneous catheterization and embolization of the thoracic duct: prospective trial.  J Vasc Interv Radiol. 1999;  10 1248-1254
• 49 Cope C. Management of chylothorax via percutaneous embolization.  Curr Opin Pulm Med. 2004;  10 311-314
• 50 Bybel B, Neumann D R, Kim B Y, Amin K, Rice T. Lymphoscintigraphy using (99m)Tc filtered sulfur colloid in chylothorax: a case report.  J Nucl Med Technol. 2001;  29 30-31
• 51 Cerfolio R J, Allen M S, Deschamps C, Trastek V F, Pairolero P C. Postoperative chylothorax.  J Thorac Cardiovasc Surg. 1996;  112 1361-1365, discussion 1365–1366
• 52 Cerfolio R J. Chylothorax after esophagogastrectomy.  Thorac Surg Clin. 2006;  16 49-52
• 53 Dougenis D, Walker W S, Cameron E W, Walbaum P R. Management of chylothorax complicating extensive esophageal resection.  Surg Gynecol Obstet. 1992;  174 501-506
• 54 Graham D D, McGahren E D, Tribble C G, Daniel T M, Rodgers B M. Use of video-assisted thoracic surgery in the treatment of chylothorax.  Ann Thorac Surg. 1994;  57 1507-1511, discussion 1511–1512
• 55 Patterson G A, Todd T R, Delarue N C, Ilves R, Pearson F G, Cooper J D. Supradiaphragmatic ligation of the thoracic duct in intractable chylous fistula.  Ann Thorac Surg. 1981;  32 44-49
• 56 Weems B F. Cholesterolhydrothorax.  Am J Med Sci. 1918;  156 20
• 57 Wrightson J M, Stanton A E, Maskell N A, Davies R J, Lee Y C. Pseudochylothorax without pleural thickening: time to reconsider pathogenesis?.  Chest. 2009;  136 1144-1147
• 58 Ferguson G C. Cholesterol pleural effusion in rheumatoid lung disease.  Thorax. 1966;  21 577-582
• 59 Garcia-Zamalloa A, Ruiz-Irastorza G, Aguayo F J, Gurrutxaga N. Pseudochylothorax: report of 2 cases and review of the literature.  Medicine (Baltimore). 1999;  78 200-207
• 60 Coe J E, Aikawa J K. Cholesterol pleural effusion: report of 2 cases studied with isotopic techniques and review of the world literature.  Arch Intern Med. 1961;  108 763-774
• 61 Hillerdal G. Chyliform (cholesterol) pleural effusion.  Chest. 1985;  88 426-428
• 62 Hillerdal G. Chylothorax and pseudochylothorax.  Eur Respir J. 1997;  10 1157-1162
• 63 Hamm H, Pfalzer B, Fabel H. Lipoprotein analysis in a chyliform pleural effusion: implications for pathogenesis and diagnosis.  Respiration. 1991;  58 294-300
• 64 Nogueras C, Monteagudo M, Vila M, Cabezuelo A, Mariscal D, Berlanga E. Recent-onset tuberculous pleurisy presenting as pseudochylothorax.  Am J Med. 2002;  113 166-168
• 65 Sassoon C S, Light R W. Chylothorax and pseudochylothorax.  Clin Chest Med. 1985;  6 163-171
• 66 Goldman A, Burford T H. Cholesterol pleural effusion: a report of 3 cases with a cure by decortication.  Dis Chest. 1950;  18 586-594